PRODUCTS
| Product Name | Strength | Image (not to scale) | Pack Size | NDC # | RLD / Brand Name | TE Rating | Therapeutic Category |
|---|---|---|---|---|---|---|---|
| Clomipramine Hydrochloride Capsules USP | 68180-0492-06 |
25mg |
 |
30 |
Anafranil® |
Tricyclic Antidepressant |
|
| Clomipramine Hydrochloride Capsules USP | 68180-0492-01 |
25mg |
|
100 |
Anafranil® |
Tricyclic Antidepressant |
|
| Clomipramine Hydrochloride Capsules USP | 68180-0493-06 |
50mg |
|
30 |
Anafranil® |
Tricyclic Antidepressant |
|
| Clomipramine Hydrochloride Capsules USP | 68180-0493-01 |
50mg |
|
100 |
Anafranil® |
Tricyclic Antidepressant |
|
| Clomipramine Hydrochloride Capsules USP | 68180-0494-06 |
75mg |
|
30 |
Anafranil® |
Tricyclic Antidepressant |
|
| Clomipramine Hydrochloride Capsules USP | 68180-0494-01 |
75mg |
|
100 |
Anafranil® |
Tricyclic Antidepressant |
|
| Cyclosporine Ophthalmic Emulsion | 0.05% |
|
30 |
68180-214-30 |
Restasis® |
NA |
Calcineurin inhibitor immunosuppressants |
| Droxidopa Capsules | 100mg |
 |
90 |
68180-987-09 |
Northera® |
AB |
Alpha and beta-adrenergic agonists |
| Droxidopa Capsules | 200mg |
 |
90 |
68180-988-09 |
Northera® |
AB |
Alpha and beta-adrenergic agonists |
| Droxidopa Capsules | 300mg |
 |
90 |
68180-989-09 |
Northera® |
AB |
Alpha and beta-adrenergic agonists |
| Fenofibrate Capsules | 30mg |
 |
30 |
68180-745-06 |
Antara® |
AB |
Antihyperlipidemic |
| Fenofibrate Capsules | 90mg |
|
30 |
68180-746-06 |
Antara® |
AB |
Antihyperlipidemic |
*All registered trademarks are the property of their respective owners. These products are intended for U.S. residents only.
